Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2025Open Access

Prognostic Impact of Lymphocyte to Monocyte Ratio in Patients with Myelodysplastic Neoplasms/Syndromes

View Full Paper
Ask AI
Bookmark
Share

Authors

WLWan‐Hsuan LeeCLChien‐Chin LinCTCheng‐Hong Tsai

Discussion

Loading...

Member takes

Overview

Retrospective analysis associates lymphocyte-to-monocyte ratio with survival outcomes in patients, indicating its prognostic significance.

Key Points

  • Elevated lymphocyte-to-monocyte ratio predicts inferior leukemia-free and overall survival in MDS patients.
  • Patients with high L/M ratios displayed notable age, platelet counts, and genetic mutation differences.
  • Retrospective analysis utilized Kaplan–Meier methods and multivariable Cox regression to assess survival outcomes.
  • Incorporating lymphocyte-to-monocyte ratio into existing risk models may enhance prognosis and treatment planning.

Cite This Study

Lee et al. (2025) studied this question.

synapsesocial.com/papers/68de5da283cbc991d0a206ebhttps://doi.org/10.21203/rs.3.rs-7524368/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-R2025 · 1 citations
  2. 2Association between lymphocyte-associated ratios, C-reactive protein and prognostic value in myelodysplastic syndromes2025 · 2 citations
  3. 3Distinct distributions of lymphocyte subsets in myelodysplastic syndrome correlate with risk stratification2025
  4. 4From chaos to clarity? decoding the inflammatory profiles in lower-risk MDS2025
  5. 5Prognostic Significance of Pre-Treatment Serum Markers in Muscle-Invasive Bladder Cancer Under Tri-Modality Therapy2025